insulin icodec/semaglutide Icodec + Semaglutide (IcoSema / Kyinsu) A fixed-dose combination of: Basal insulin icodec (ultra-long acting) GLP-1 receptor agonist semaglutide Designed for once-weekly subcutaneous injection Current Status Completed Phase 3 trials (COMBINE Awiqli Once-Weekly Basal Insulin for
Pay in 4 interest-free payments of $6.92 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

00096-8/asset/caa529f2-bb62-4b69-b63d-6c9469fb372e/main.assets/gr2_lrg.jpg)







:max_bytes(150000):strip_icc()/GettyImages-1758233726-9eb529f998844ee8adb39aeb580f0726.jpg)



















